Form 4: Precigen Director Sells $15.7M in Stock

Randal J. Kirk, a Director and 10% owner of Precigen, Inc., reported the sale of over 4.7 million shares of common stock for approximately $15.7 million.

Summary

• Randal J. Kirk, a Director and 10% owner of Precigen, Inc. (PGEN), reported the sale of 4,777,781 shares of common stock.
• The sales occurred on March 30, 2026, at a weighted average price of $3.3 per share, with prices ranging from $3.22 to $3.58.
• The total value of the shares sold is approximately $15,766,677.30.
• The shares were sold indirectly through various entities controlled by Mr. Kirk, including R.J. Kirk Declaration of Trust, JPK LLCs, MGK LLCs, ZSK LLCs, Kellie L. Banks LTT, and Sunset 2020, LLC.
• Following these transactions, Mr. Kirk's indirectly held beneficial ownership in Precigen, Inc. totals 116,301,190 shares.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative signal due to the significant insider selling by a director and major shareholder, which often indicates a lack of confidence or belief that the stock is overvalued.

Negatives

• A significant insider sale by a Director and 10% owner, Randal J. Kirk, totaling 4,777,781 shares, could be interpreted as a lack of confidence in the company's near-term prospects.
• The sale of approximately $15.7 million worth of stock represents a substantial divestment by a key insider.

Risks

• Investor sentiment may be negatively impacted by the significant insider selling, potentially leading to downward pressure on the stock price.
• The sale by a 10% owner and Director could signal concerns about future company performance or valuation.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that significant insider selling, especially by a director and major shareholder, can sometimes precede periods of underperformance or reflect a belief that the stock is fully valued. This transaction occurs within the broader biotechnology sector, where investor confidence is often tied to clinical trial results, regulatory approvals, and strategic partnerships. While not directly tied to operational news, such a large sale by a key insider could be viewed cautiously by the market.

Related Party Transactions

• The shares were sold indirectly through various entities controlled by Randal J. Kirk, including R.J. Kirk Declaration of Trust, JPK 2008 LLC, JPK 2009 LLC, JPK 2012 LLC, MGK 2008 LLC, MGK 2009 LLC, MGK 2011 LLC, ZSK 2008 LLC, ZSK 2009 LLC, Kellie L. Banks (2009) Long Term Trust, and Sunset 2020, LLC.
• Mr. Kirk disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein.

Stakeholder Impact

• Shareholders: May interpret the insider sale as a negative signal, potentially leading to decreased investor confidence and downward pressure on the stock price.
• Employees: No direct impact mentioned, but a significant insider sale could indirectly affect morale if perceived as a lack of confidence in the company's future.

Key Dates

Recommendation

The substantial insider selling by a Director and 10% owner, Randal J. Kirk, for approximately $15.7 million, signals a significant lack of confidence in Precigen's current valuation or future prospects. Such a large divestment by a key insider typically precedes periods of underperformance or indicates that the stock is considered overvalued, prompting a 'sell' recommendation for investors.

Keywords

Precigen, PGEN, Randal J. Kirk, Insider Sale, Form 4, SEC Filing, Stock Transaction, Director Sale, 10% Owner, Common Stock